copyright and Wegovy, two recent developments in the field of weight management, have attracted significant attention for their promising results. These medications, both belonging to a class called GLP-1 receptor agonists, work by regulating the body's natural processes to minimize appetite and improve insulin sensitivity. Early clinical trials h